Ocular Therapeutix (OCUL) Misses Q3 EPS by 1c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $523 thousand versus the consensus estimate of $510 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations